Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
Consumer OTC Drugs

Forty-Two AGs Weigh In: Ariva “Cigalett” Falls Under FDA Oversight

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

The Supreme Court's findings in FDA v. Brown & Williamson Tobacco Corp. allow the agency to regulate Star Scientific's Ariva "cigalett" smokeless tobacco product as either a food or a drug, according to comments from 42 state attorneys general

You may also be interested in...



Star Scientific Defends Ariva As “Compressed Version” Of Dry Snuff

Ariva "cigalett" pieces should be classified as a smokeless tobacco product and not a food despite containing ingredients other than tobacco such as sweeteners and natural and artificial flavorings, marketer Star Scientific contends

Nicotine Lollipops Active Ingredient Nicotine Salicylate “Illegal” – FDA

The Professional Compounding Centers of America is urging its members to switch from nicotine salicylate to nicotine polacrilex when compounding lollipops to help patients quit smoking

Ariva “Cigalett” Pieces Are Foods, Not Smokeless Tobacco Items, GSK Says

Star Scientific's Ariva "cigalett" pieces and other candy-like products containing tobacco do not fall within the definition of smokeless tobacco products, GlaxoSmithKline says in a citizen petition filed with FDA Feb. 15
Table

View full table

Related Content

Pink Sheet Pink Sheet

Topics

Tags:
Consumer OTC Drugs
UsernamePublicRestriction

Register

PS094295

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By